8-KOther EventsExhibits & Filings

Corteva, Inc. 8-K Report, Corporate Update (Sep 10, 2026)

Filed September 10, 2026For Securities:CTVA

Summary

Corteva, Inc. (CTVA) announced a significant settlement on September 9, 2026, resolving statewide PFAS claims and specific site-related issues in North Carolina. As part of this agreement, Corteva and its subsidiary EIDP, Inc. will collectively pay approximately $66 million over 15 years. This settlement is a component of a larger collective payment of $455 million by Corteva, EIDP, The Chemours Company, and DuPont de Nemours, Inc. to the State of North Carolina and its subdivisions. Furthermore, Corteva and DuPont will jointly guarantee Chemours' share of the settlement payments and establish a reserve fund of up to $135 million. This settlement also impacts the existing Memorandum of Understanding (MOU) among the parties. The North Carolina settlement payments will be applied against the MOU's $4 billion qualified spend cap, valued at their net present value ($210 million), and will satisfy future escrow contribution obligations, alleviating future cash requirements for these specific obligations.

Key Highlights

  • 1Corteva and subsidiaries EIDP, Inc. reached a settlement with North Carolina and its subdivisions for $66 million, payable over 15 years.
  • 2The settlement resolves statewide PFAS claims and issues related to historical discharges from the Fayetteville Works site.
  • 3Corteva and DuPont will jointly guarantee Chemours' portion of the settlement payments.
  • 4A reserve fund of up to $135 million will be established via credit lines, letters of credit, or surety bonds to secure Chemours' compliance with its NC Consent Order.
  • 5The North Carolina settlement payment's net present value of $210 million will be applied against the $4 billion qualified spend cap under the existing MOU.
  • 6The settlement payments will satisfy all future contributions required by the parties to the MOU Escrow Account.

Frequently Asked Questions

Corteva's direct financial obligation for this settlement is approximately $66 million, to be paid over 15 years. Additionally, the company may have contingent liabilities related to guaranteeing Chemours' share and establishing a reserve fund of up to $135 million, though the need for these contingent payments depends on Chemours' compliance.

The settlement significantly impacts the MOU by applying its net present value ($210 million) against the $4 billion qualified spend cap. Critically, these settlement payments will also fulfill all future escrow contribution obligations required by the parties under the MOU, reducing future cash outlay for that purpose.

Corteva, along with DuPont, is required to guarantee Chemours' settlement payments. Furthermore, a reserve fund, accessible by North Carolina if Chemours fails to comply with its NC Consent Order, will be established with a cap of $135 million. Corteva's involvement in this reserve fund is on a 29% basis with DuPont covering 71%.

Beyond the $66 million directly attributed to Corteva, the primary additional financial risk lies in the guarantee of Chemours' settlement payments and the establishment of the reserve fund, capped at $135 million. The ultimate outflow from these contingent arrangements depends on Chemours' performance and compliance with its obligations.